Zimmer Biomet Holdings Inc at JPMorgan Healthcare Conference Transcript
Good afternoon. I'm Robbie Marcus, the med tech analyst at JPMorgan. I'm very happy to host my next session with Zimmer Biomet. I have the CEO, Bryan Hanson; and the CFO, Suky Upadhyay. I think I was close there. Sorry, Suky. So we're going to diverge a little bit from the format we had for some of the other sessions. We're going to do 20 minutes of Q&A that allows Zimmer Biomet to highlight some of the really key topics today, and then we're going to move into 20 minutes of a little less formal Q&A. Please feel free to submit questions or e-mail me and I can do my best to get to all of them.
Questions & Answers
But Bryan, Suky maybe to kick it off, Bryan, you've been at Zimmer Biomet for 4 years now. You've undergone this really big transformation process. Where do you sit now in the total process for Zimmer Biomet?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |